Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial